Protection against cerebral malaria by the low-molecular-weight thiol pantethine. - Wikidata - wikimedia - TriplyDB

Protection against cerebral malaria by the low-molecular-weight thiol pantethine.

Protection against cerebral malaria by the low-molecular-weight thiol pantethine.

http://www.wikidata.org/entity/Q36446215

about

Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome Microparticles as mediators and biomarkers of rheumatic disease A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malaria Infectious Diseases of the Nervous System and Their Impact in Developing Countries Integrated electroosmotic perfusion of tissue with online microfluidic analysis to track the metabolism of cystamine, pantethine, and coenzyme A.Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria.Effect of Pantethine on Ovarian Tumor Progression and Choline Metabolism.Elevated cell-specific microparticles are a biological marker for cerebral dysfunctions in human severe malaria.Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury.Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate.Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine.Diagnosis and management of the neurological complications of falciparum malaria Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria Investigation of hydrogen sulfide gas as a treatment against P. falciparum, murine cerebral malaria, and the importance of thiolation state in the development of cerebral malaria.Lipoxin A₄ and 15-epi-lipoxin A₄ protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brain Production, fate and pathogenicity of plasma microparticles in murine cerebral malaria.Plant Hormone Salicylic Acid Produced by a Malaria Parasite Controls Host Immunity and Cerebral Malaria Outcome Microparticles as immune regulators in infectious disease - an opinion Experimental Models of Microvascular Immunopathology: The Example of Cerebral Malaria.Pathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches.Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium.Exploring experimental cerebral malaria pathogenesis through the characterisation of host-derived plasma microparticle protein content Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?The immunological balance between host and parasite in malaria.Cerebral malaria--clinical manifestations and pathogenesis.Pantethine Alters Lipid Composition and Cholesterol Content of Membrane Rafts, With Down-Regulation of CXCL12-Induced T Cell Migration.Imbalance of the Vanin-1 Pathway in Systemic Sclerosis.The diabetic brain and cognition.Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy.Pantethine Prevents Murine Systemic Sclerosis Through the Inhibition of Microparticle Shedding.Splenocyte apoptosis in Plasmodium berghei ANKA infection: possible role of TNF-α and TGF-β.Do we know enough to find an adjunctive therapy for cerebral malaria in African children?Pantethine Down-Regulates Leukocyte Recruitment and Inflammatory Parameters in a Mouse Model of Allergic Airway Inflammation.Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside.Malaria infected red blood cells release small regulatory RNAs through extracellular vesicles.Application of Metabolomics in Alzheimer's Disease.Differential plasma microvesicle and brain profiles of microRNA in experimental cerebral malaria.

P2860

Q21032453-4051533A-A0E6-41BE-B00C-19504F2A7A89 Q27016054-008B0696-BE55-4D68-91D6-0808C53F13E9 Q27318676-ABF55891-4DF7-4463-9932-AF7AAE7EA15F Q27487936-8BE76BAB-B531-4E9D-BAE3-A191264DA98F Q30409061-A9ACB601-EBE3-4EE6-8480-2CB2BCCB6931 Q30411019-FE608526-8F3A-4202-AFC9-AFEAAB1EA48C Q31145516-09E8FC04-8B1B-4BD7-A79F-904AA4BF6650 Q33392460-EFCF7720-AF24-46CE-8D2D-4633E14767A7 Q33563284-E1F3BAFD-A079-452F-998B-6DDB134734D7 Q33564441-45E00746-ECBF-4127-BF32-774E2C2515A8 Q33565510-26850A2B-2D15-4D47-B7C0-E0D4AE60019D Q33808801-52311994-C8CE-4F10-81C6-1C19E630497B Q34328743-A97EFC0D-284F-4462-B35D-27F6F56E3845 Q34650997-7391EA2C-84CB-4ACF-A930-53260699B416 Q34685370-8BE242BB-AF1D-47DD-B089-C0CAA6B7A711 Q35126111-25EEB58E-D064-465E-8DFB-37E6D6A5E584 Q35806583-096A9CA2-C269-4B78-B2B7-19CEBE998D88 Q35928145-6DA2062E-CA04-4400-B167-85A1197C0E2E Q36100829-1BEF760E-782A-4C2A-9F8D-C5D3E7DBD2A4 Q36209383-850CEBDC-216D-4338-BA06-178FC5FED1BB Q36788489-2AADD901-0FB1-4453-BEF3-85AE558C740A Q37472712-93B28CB1-83CE-4D99-A2F4-E4E316013C48 Q37663392-79383272-6FBB-40E4-97F7-1411550593CB Q38666558-06FAA4F0-E7EF-4161-A4D3-131DCBF40617 Q38690668-08A77366-69FB-4C19-B20A-2725293F047A Q38904933-F4EA34D2-49C4-4A48-9BEE-68B119B388B0 Q39372194-C181C06D-6670-4A78-9F08-AD54457EF3BC Q40098573-35C3C687-CD56-4540-B959-F888068A3060 Q42229140-649E24CC-53A8-4805-8CB8-23800D8601EE Q42474294-A626E728-D9DF-4A6D-9925-2ED1714379D1 Q44083043-A8FB36C3-5224-4F2C-B91C-47F73DEC9707 Q46237821-0D0B10F3-CEDE-4415-BE70-0D67DFA1E8A3 Q47137222-0E0CEA20-E7B5-4885-BB63-8DEC50FDE974 Q47622685-76D228AA-892F-401B-AFD7-780AD31DC7D4 Q48022347-34186AD2-D9D5-48E9-AC29-B185F1DB0C27 Q49464422-F886814C-C90E-49B2-A5F4-EFB22A9BC697 Q55384045-F3DC907C-770E-4243-9248-573ABC56A2D4

P2860

Protection against cerebral malaria by the low-molecular-weight thiol pantethine.

http://www.wikidata.org/entity/Q36446215

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Protection against cerebral malaria by the low-molecular-weight thiol pantethine.

@ast

Protection against cerebral malaria by the low-molecular-weight thiol pantethine.

@en

type

label

Protection against cerebral malaria by the low-molecular-weight thiol pantethine.

@ast

Protection against cerebral malaria by the low-molecular-weight thiol pantethine.

@en

prefLabel

Protection against cerebral malaria by the low-molecular-weight thiol pantethine.

@ast

Protection against cerebral malaria by the low-molecular-weight thiol pantethine.

@en

P1433

Q36446215-BDDB1D96-D340-4CC5-A45B-88B6872829B0

P1476

Q36446215-4E87BC0C-78C9-4048-8F01-BCBFB995EECE

P2093

Q36446215-0403C7A1-E999-42B9-A92F-7198A2B09DF9

Q36446215-43B95618-5FC8-4AED-BDB1-5610B2412CD8

Q36446215-6094EAED-448F-4C28-BDC5-D2EAE5F2D947

Q36446215-74973FA3-0A3C-458E-8AA0-69CF0E3216CA

Q36446215-856239AA-BA44-4E5F-A582-5D5A833FC5AF

Q36446215-D2857565-8696-4047-9878-A2EFAE766AA8

Q36446215-DF5F1458-996D-4607-BB91-A47F0FBD636F

P2860

Q36446215-01BA7EE1-A093-4059-9374-51763994CB39

Q36446215-0AEE9549-E439-4DA9-9EE1-181BA40FF4BB

Q36446215-14413EC6-E7B1-45DB-B766-B0C4CB9A932D

Q36446215-18E93F91-20F0-4E09-8912-D4255383C812

Q36446215-1A772F06-5B93-4F3D-8A79-AAC81FE7C158

Q36446215-20BDEBF9-DE69-4E38-9DE5-76D0C9DC3D03

Q36446215-22BDFEB1-1BB3-424E-AF53-788895D32F9C

Q36446215-25935736-5441-45EB-AEAB-1442BFC1CCC5

Q36446215-324D898D-713B-464B-A5BC-1ECFC4086212

Q36446215-428D51A0-93CA-46C7-99E0-29743DC554FB

P304

Q36446215-A8DD5738-2D7E-4680-8BEE-2906908FC392

P31

Q36446215-4F643644-912E-4080-BF2D-A2635582441B

P356

Q36446215-F0DBAF5D-8365-4EBE-81AF-07A2B9E64EAE

P407

Q36446215-88517F93-52AE-4F50-97B2-56609C059619

P433

Q36446215-8351C731-0810-4245-99D3-09DDA9511148

P478

Q36446215-B197CD47-CD58-47C9-831D-4D7B9E687AED

P577

Q36446215-A7FF8FF3-39A7-4F5E-977C-BEB4BDCE5AB6

P5875

Q36446215-B371E929-1BBD-405B-8DED-D0028B2E1306

P698

Q36446215-297CF8E8-6F2E-4EC8-B32B-E25684595FF3

P921

Q36446215-2C90F94B-6675-47F8-AC4F-BDEF94A4592F

Q36446215-E69E1311-DB4B-4AF6-AD56-76ABA88B4EE8

P932

Q36446215-1E292838-55C2-4400-A860-6F450250F830

P356

PNAS.0706867105

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Protection against cerebral malaria by the low-molecular-weight thiol pantethine.

@en

P2093

Bouchra Gharib

http://www.w3.org/2001/XMLSchema#string

Emilie Cornille

http://www.w3.org/2001/XMLSchema#string

Georges E Grau

http://www.w3.org/2001/XMLSchema#string

Marie-France Penet

http://www.w3.org/2001/XMLSchema#string

Max de Reggi

http://www.w3.org/2001/XMLSchema#string

Mhamad Abou-Hamdan

http://www.w3.org/2001/XMLSchema#string

Nicolas Coltel

http://www.w3.org/2001/XMLSchema#string

P2860

Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease)

Vanin-1(-/-) mice show decreased NSAID- and Schistosoma-induced intestinal inflammation associated with higher glutathione stores

Surface exposure of phosphatidylserine in pathological cells

ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine

Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans.

Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes

Assessing vascular permeability during experimental cerebral malaria by a radiolabeled monoclonal antibody technique.

Susceptibility to experimental cerebral malaria induced by Plasmodium berghei ANKA in inbred mouse strains recently derived from wild stock.

The role of cerebral oedema in the pathogenesis of cerebral malaria.

Immunological processes in malaria pathogenesis.

P304

1321-1326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0706867105

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5656926

http://www.w3.org/2001/XMLSchema#string

P698

18195363

http://www.w3.org/2001/XMLSchema#string

P921

cerebral malaria

P932

2234136

http://www.w3.org/2001/XMLSchema#string